EyePoint, Inc (EYPT NASDAQ) stock market data APIs
$12.8004
-0.52(-4.1%)
as of August 6, 2026
Try our APIs with
free plan!
EyePoint, Inc Financial Data Overview
Price chart is built with
Anychart
EyePoint, Inc. engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases. The company's pipeline leverages its proprietary bioerodible Durasert E technology for sustained intraocular drug delivery. Its lead product candidate is DURAVYU, an investigational sustained delivery treatment for vascular endothelial growth factor mediated retinal diseases combining vorolanib, a selective and patent-protected tyrosine kinase inhibitor with Durasert E which is in Phase 3 clinical trials for wet age-related macular degeneration (wet AMD), and diabetic macular edema (DME). The company's pipeline programs also include EYP-2301, a promising TIE-2 agonist formulated in Durasert E that is in pre-clinical development phase for potentially improve outcomes in serious retinal diseases. The company was formerly known as EyePoint Pharmaceuticals, Inc. and changed its name to EyePoint, Inc. in December 2025. EyePoint, Inc. was founded in 2000 and is headquartered in Watertown, Massachusetts.
Prev. Close
12.8004
Open
12.2823
High
12.9669
Low
12.0777
52 wk Range
9.65-19.11
Market Cap
1 076 M
Shares Outstanding
83 841 K
Revenue
2 788 K
EPS
-1.09
Beta
1.739
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with EyePoint, Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at €19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only €19.99
TRY NOW
Get EyePoint, Inc data using free add-ons & libraries
Get EyePoint, Inc Fundamental Data
EyePoint, Inc Fundamental data includes:
- Net Revenue: 2 788 K
- EBITDA: -314 430 016
- Earnings Per Share: -3
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
€
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-08-05
- EPS/Forecast: -0.92
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
EyePoint, Inc News
New
Beam Therapeutics Inc. (BEAM) Reports Q2 Loss, Lags Revenue Estimates
Beam Therapeutics Inc. (BEAM) came out with a quarterly loss of $1.18 per share versus the Zacks Consensus Estimate of a loss of $1. This compares to a loss of $1 per share a year ago. These figures a...
Earnings Preview: EyePoint (EYPT) Q2 Earnings Expected to Decline
Wall Street expects a year-over-year decline in earnings on lower revenues when EyePoint (EYPT) reports results for the quarter ended June 2026. While this widely-known consensus outlook is important ...
EyePoint to pay $4.6M to settle with DoJ over kickback claims
[Black stethoscope and US dollar bills on light blue background] Muhammad Labib Adilah/iStock via Getty Images The U.S. Department of Justice announced on Friday that EyePoint Pharmaceuticals (EYPT [...
EyePoint Appoints Tarek S. Hassan, M.D., as Chief Strategic Science Officer
WATERTOWN, Mass., July 13, 2026 (GLOBE NEWSWIRE) -- EyePoint, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with...
Get EyePoint, Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
€19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only €19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
€99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
